Quest Diagnostics
DGX
#1022
Rank
โ‚น2.276 T
Marketcap
โ‚น20,563
Share price
1.92%
Change (1 day)
34.41%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2026 (TTM): โ‚น819.41

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น872.89. In 2025 the company made an earnings per share (EPS) of โ‚น844.34 an increase over its 2024 EPS that were of โ‚น740.58.

EPS history for Quest Diagnostics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น819.41-2.95%
2025โ‚น844.3414.01%
2024โ‚น740.582.5%
2023โ‚น722.49-5.83%
2022โ‚น767.23-49.21%
2021โ‚น1,51149.72%
2020โ‚น1,00966.67%
2019โ‚น605.4118%
2018โ‚น513.07-4.26%
2017โ‚น535.9223.19%
2016โ‚น435.02-7.11%
2015โ‚น468.3328.46%
2014โ‚น364.58-31.61%
2013โ‚น533.0660.46%
2012โ‚น332.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น1,081 23.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น67.75-107.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น79.96-109.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น196.10-77.53%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น19.99-102.29%๐Ÿ‡บ๐Ÿ‡ธ USA